Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CytoViva is a specialized provider of optical microscopy and hyperspectral imaging technologies tailored for the nanotechnology and life sciences sectors. The company's proprietary technology integrates enhanced darkfield microscopy with high-resolution hyperspectral imaging, enabling the label-free visualization and chemical characterization of nanomaterials within complex biological environments. These systems are primarily utilized by researchers to track drug delivery vehicles, study nanotoxicology, and analyze material properties at the nanoscale. Based in Auburn, Alabama, CytoViva supports a diverse range of applications across academia, government research, and the pharmaceutical industry. The company's solutions are critical for advancing the development of nanomedicines by providing quantitative data on nanoparticle-cell interactions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CytoViva.